The PD-1-deficient CAR T cells presented similar rates of cytokine generation and amended proliferation and cytotoxicity in vitro, and improved the reserve of tumor development in glioma cell-bearing mice. This evidence concerns the gene PDCD1 and central nervous system cancer.